A synthetic analog of the naturally occurring alpha-melanocyte-stimulating hormone (α-MSH) that is clinically utilized to induce melanogenesis, resulting in skin darkening or tanning without extensive sun exposure. This peptide acts as a potent agonist at certain melanocortin receptors, primarily MC1R, offering a method to increase melanin production. It is noted for its potential to alter pigmentation and its off-target effects on appetite and sexual function.
Origin
The peptide was originally developed and studied in the late 1980s at the University of Arizona for its potential as a photoprotective agent to help prevent skin cancer. Its name is a combination of “Melano-” referring to melanin and “tan” describing its primary visible effect on skin pigmentation.
Mechanism
Melanotan II binds selectively to melanocortin receptors, especially the MC1 receptor found on melanocytes, triggering an intracellular signaling cascade involving adenylyl cyclase and protein kinase A (PKA). This cascade ultimately stimulates the production and dispersion of the dark melanin pigment within the skin, providing a darker complexion and potential photoprotection.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.